Acute Myeloid Leukemia - The Leukemia & Lymphoma Society

More documents

Recommendations

Info

Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W,Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP,Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer.Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD,www.seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER datasubmission, posted to the SEER website, 2011.Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation foracute myeloid leukemia in first complete remission: systematic review and metaanalysisof prospective clinical trials. Journal of the American Medical Association.2009;301(22):2349-2361.Kotiah SD. Acute Promyelocytic Leukemia Treatment & Management.Medscape Reference Web site 2011. Available at www.emedicine.medscape.com/article/1495306-treatment. Accessed October 25, 2011.Liesveld JL, Lichtman MA. Chapter 89. Acute myelogenous leukemia. KaushanskyK, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal J, eds. WilliamsHematology. 8th ed. Available from: AccessMedicine. Accessed October 25, 2011.Manola KN. Cytogenetics of pediatric acute myeloid leukemia. European Journalof Haematology. 2009;83(5):391-405.The Leukemia & Lymphoma Society’sLight The Night WalkTaking Steps toCure CancerTMLIGHTTHENIGHT.ORG877.LTN.WALKpage 52 I 800.955.4572 I www.LLS.org
REACH OUT TO OURINFORMATION SPECIALISTSThe Leukemia & LymphomaSociety’s (LLS) InformationSpecialists provide patients,families and healthcareprofessionals with the latestinformation on leukemia,lymphoma and myeloma.Our team consists of master’slevel oncology professionals whoare available by phone Mondaythrough Friday, 9 am to 6 pm (ET).Co-Pay AssistanceLLS’s Co-Pay Assistance Programhelps blood cancer patients coverthe costs of private and publichealth insurance premiums,including Medicare and Medicaid,and co-pay obligations. Supportfor this program is based on theavailability of funds by disease.For more information,call 877.557.2672 orvisit www.LLS.org/copay.For a complete directory of our patient services programs, contact us at800.955.4572 or www.LLS.org(Callers may request a language interpreter.)
Page 2:
A Message From John WalterPresident
Page 5 and 6: LLS Has Ways to Help. Treatment for
Page 7 and 8: Depression. Treatment for depressio
Page 9 and 10: AML may develop from the progressio
Page 11 and 12: DiagnosisAn accurate diagnosis of t
Page 13 and 14: Other Tests. “Karyotyping” and
Page 15 and 16: Table 2. Some AML Risk FactorsCerta
Page 17 and 18: Talk to yourdoctor aboutYour treatm
Page 19 and 20: Postremission Therapy. Normal blood
Page 21 and 22: ill to have an allogeneic stem cell
Page 23 and 24: All-trans retinoic acid (ATRA), a v
Page 25 and 26: Children who have AML are treated w
Page 27 and 28: Other Side Effects. Chemotherapy af
Page 29 and 30: Treatment Outcomes. Patients with A
Page 31 and 32: Research and Clinical TrialsThe pro
Page 33 and 34: Normal Blood and MarrowBlood is com
Page 35 and 36: Medical TermsAbsolute Neutrophil Co
Page 37 and 38: abnormalities in cancer cells. No s
Page 40 and 41: Colony-Stimulating Factor. See Grow
Page 42 and 43: Extramedullary Myeloblastoma. See C
Page 44 and 45: Hematologist. A medical doctor who
Page 46 and 47: Inversion. An abnormality of chromo
Page 48 and 49: somatic mutations, leading to the f
Page 50 and 51: of one blood cancer cell among 500,
Page 52 and 53: Stem Cells. Primitive cells in marr
Page 56: For more information, please contac
show all

Acute Myeloid Leukemia - The Leukemia & Lymphoma Society

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?